$CVS · CVS HEALTH Corp
CVS Health announced intent to split into two public companies: a healthcare solutions company (Aetna, CVS Caremark, CVS Specialty, Oak Street Health, Signify Health) retaining the CVS Health name, and CVS Pharmacy (roughly 9,000 retail pharmacies, mail pharmacy, MinuteClinic, Health100). The separation is intended to be tax-free and is expected to complete in H1 2028, subject to Board approval, a Form 10 registration statement, and tax confirmation. David Joyner will lead the healthcare solutions company; Prem Shah will be CEO of CVS Pharmacy. Both companies are expected to hold investment-grade ratings and pay dividends.
- Separation expected to complete in the first half of 2028, structured as tax-free to shareholders.
- Healthcare solutions company keeps Aetna, CVS Caremark, CVS Specialty, Oak Street Health, and Signify Health.
- CVS Pharmacy will hold approximately 9,000 retail pharmacies, mail pharmacy, MinuteClinic, and Health100.
- David Joyner to lead healthcare solutions; Prem Shah to be CEO of CVS Pharmacy.
- Both companies expected to have investment-grade ratings, strong free cash flow, and attractive dividends.
Markets closed — no regular-session reaction yet; extended-hours last trade $91.51, +0.11% vs regular close.
A $116.9B healthcare giant unwinding its vertical integration into two focused public companies is a major strategic reset for investors.
Follows a broader trend of healthcare conglomerates unwinding vertical integration, echoing similar payer-pharmacy separations to unlock focus and valuation.
Separation may not occur or may not qualify for expected tax treatment; dis-synergy and restructuring costs could exceed estimates, and anticipated benefits may not materialize.